Celcuity (CELC) Competitors $54.91 -2.52 (-4.39%) Closing price 04:00 PM EasternExtended Trading$54.44 -0.46 (-0.85%) As of 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CELC vs. GH, RDNT, OPCH, SHC, BTSG, WGS, CON, SGRY, PRVA, and HTFLShould you be buying Celcuity stock or one of its competitors? The main competitors of Celcuity include Guardant Health (GH), RadNet (RDNT), Option Care Health (OPCH), Sotera Health (SHC), BrightSpring Health Services (BTSG), GeneDx (WGS), Concentra Group Holdings Parent (CON), Surgery Partners (SGRY), Privia Health Group (PRVA), and Heartflow (HTFL). These companies are all part of the "healthcare" industry. Celcuity vs. Its Competitors Guardant Health RadNet Option Care Health Sotera Health BrightSpring Health Services GeneDx Concentra Group Holdings Parent Surgery Partners Privia Health Group Heartflow Guardant Health (NASDAQ:GH) and Celcuity (NASDAQ:CELC) are both mid-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, valuation, dividends, institutional ownership, profitability, analyst recommendations, earnings and risk. Do analysts rate GH or CELC? Guardant Health currently has a consensus price target of $58.24, suggesting a potential upside of 6.08%. Celcuity has a consensus price target of $56.50, suggesting a potential upside of 2.90%. Given Guardant Health's stronger consensus rating and higher probable upside, equities analysts plainly believe Guardant Health is more favorable than Celcuity.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Guardant Health 0 Sell rating(s) 0 Hold rating(s) 17 Buy rating(s) 1 Strong Buy rating(s) 3.06Celcuity 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more risk and volatility, GH or CELC? Guardant Health has a beta of 1.46, meaning that its stock price is 46% more volatile than the S&P 500. Comparatively, Celcuity has a beta of 0.72, meaning that its stock price is 28% less volatile than the S&P 500. Is GH or CELC more profitable? Celcuity has a net margin of 0.00% compared to Guardant Health's net margin of -49.93%. Guardant Health's return on equity of 0.00% beat Celcuity's return on equity.Company Net Margins Return on Equity Return on Assets Guardant Health-49.93% N/A -28.95% Celcuity N/A -150.07%-64.67% Does the media refer more to GH or CELC? In the previous week, Guardant Health had 12 more articles in the media than Celcuity. MarketBeat recorded 22 mentions for Guardant Health and 10 mentions for Celcuity. Guardant Health's average media sentiment score of 1.13 beat Celcuity's score of 1.02 indicating that Guardant Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardant Health 15 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Celcuity 4 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable valuation & earnings, GH or CELC? Celcuity has lower revenue, but higher earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Celcuity, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGuardant Health$739.02M9.26-$436.37M-$3.35-16.39CelcuityN/AN/A-$111.78M-$3.45-15.92 Do institutionals & insiders hold more shares of GH or CELC? 92.6% of Guardant Health shares are held by institutional investors. Comparatively, 63.3% of Celcuity shares are held by institutional investors. 6.1% of Guardant Health shares are held by company insiders. Comparatively, 15.8% of Celcuity shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. SummaryGuardant Health beats Celcuity on 12 of the 15 factors compared between the two stocks. Get Celcuity News Delivered to You Automatically Sign up to receive the latest news and ratings for CELC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CELC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CELC vs. The Competition Export to ExcelMetricCelcuityMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.44B$3.12B$5.79B$10.15BDividend YieldN/A2.32%5.69%4.61%P/E RatioN/A21.3074.5925.92Price / SalesN/A240.30449.5483.33Price / CashN/A45.3337.0859.91Price / Book17.669.6112.156.29Net Income-$111.78M-$53.29M$3.28B$270.85M7 Day Performance-1.40%0.29%0.98%3.36%1 Month Performance9.69%8.91%7.20%6.41%1 Year Performance274.81%13.14%63.06%28.26% Celcuity Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CELCCelcuity1.4416 of 5 stars$54.91-4.4%$56.50+2.9%+269.6%$2.44BN/A0.0040Positive NewsGHGuardant Health4.0908 of 5 stars$67.42+4.6%$57.50-14.7%+128.3%$8.41B$739.02M-20.132,021News CoveragePositive NewsInsider TradeGap DownRDNTRadNet3.436 of 5 stars$71.760.0%$71.60-0.2%+18.3%$5.52B$1.83B-358.7811,021Positive NewsInsider TradeOPCHOption Care Health4.8747 of 5 stars$28.68-0.2%$35.75+24.7%-9.4%$4.65B$5.00B22.948,088Positive NewsSHCSotera Health2.1627 of 5 stars$16.37+1.0%$16.00-2.3%-0.4%$4.65B$1.10B204.653,000Insider TradeBTSGBrightSpring Health Services2.8159 of 5 stars$23.69-0.2%$25.67+8.3%+107.0%$4.20B$11.27B76.4235,000News CoverageAnalyst ForecastWGSGeneDx2.5773 of 5 stars$129.49+0.4%$101.63-21.5%+257.0%$3.72B$305.45M2,589.801,200Positive NewsAnalyst ForecastCONConcentra Group Holdings Parent3.0405 of 5 stars$23.78+0.2%$27.50+15.7%-3.7%$3.05B$1.90B19.9811,250Positive NewsSGRYSurgery Partners3.1673 of 5 stars$22.69-0.1%$33.00+45.4%-27.4%$2.91B$3.11B-15.8715,000Positive NewsPRVAPrivia Health Group4.5292 of 5 stars$23.04+5.6%$28.08+21.9%+25.5%$2.83B$1.74B209.471,140Positive NewsHTFLHeartflowN/A$31.50-2.0%N/AN/A$2.56BN/A0.00699Quiet Period ExpirationGap Up Related Companies and Tools Related Companies Guardant Health Competitors RadNet Competitors Option Care Health Competitors Sotera Health Competitors BrightSpring Health Services Competitors GeneDx Competitors Concentra Group Holdings Parent Competitors Surgery Partners Competitors Privia Health Group Competitors Heartflow Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CELC) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | SponsoredThe $17B signal no one expected…After SpaceX struck a $17 billion deal with EchoStar for a block of radio frequencies, tech analyst Jeff Brown...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Celcuity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Celcuity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
